Left Menu
Development News Edition

Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate

Brazil's Sao Paulo state is set to begin importing the first of 46 million doses of China's Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc. Federal health officials met with Pfizer representatives on Tuesday as Brazil seeks to secure vaccine supplies.

Reuters | Updated: 18-11-2020 05:42 IST | Created: 18-11-2020 05:42 IST
Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate

Brazil's Sao Paulo state is set to begin importing the first of 46 million doses of China's Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc. Federal health officials met with Pfizer representatives on Tuesday as Brazil seeks to secure vaccine supplies. The Health Ministry said in a statement that it would buy the Pfizer vaccine, currently in Phase 3 trials, if it was proven safe and was registered with health authority Anvisa.

As it draws up immunization plans, the ministry will also meet this week with Johnson & Johnson, India's Bharat Biotech and the makers of Russia's Sputnik V vaccine. Brazil has the third-highest coronavirus case count in the world, leading many pharmaceutical companies to do trials of their vaccines in South America's largest country.

State health authorities have taken a more aggressive stance than their federal counterparts on securing vaccine supplies. The director of Sao Paulo state's Butantan Institute biomedical center, Dimas Covas, told a congressional hearing on Tuesday that Butantan expected to have 46 million doses of Sinovac ready in January to be used if approved by Brazil's health regulator Anvisa.

Butantan is organizing the Phase 3 trials of the vaccine in Brazil, with Covas saying preliminary results indicate it has an excellent safety profile. Covas said 10,000 volunteers had already received about 19,000 shots of the two-dose vaccine, and 2,000 other people had still to be included in the trials.

Anvisa suspended the trials for a day and a half last week after the death of a volunteer, which police reported as a suicide and Butantan said had no relation to the vaccine. The temporary halt had no affect on the clinical trials, Covas said, adding that Butantan had a "very good understanding" with Anvisa.

Butantan and Anvisa have sent experts to China where they are in a two-week quarantine before they can visit vaccine facilities, they said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

COVID-19: At 77.2 per cent, Aurangabad sees rise in vaccinations

At least 77.2 per cent healthworkers took the COVID-19 shots in Maharashtras Aurangabaddistrict on the fourth day of the vaccination drive, aconsiderable rise from the previous sessions, an official saidon Saturday.As many as 772 health wor...

UK doctors call for shorter gap between Pfizer vaccine doses

A group of British doctors have written to Englands chief medical officer to tell him to cut the gap between doses of the Pfizer and BioNTech vaccine to six weeks from up to 12. Britain is prioritising giving first doses of COVID-19 vaccine...

At the moment, I'm not thinking about it: Hales on England recall

Alex Hales, who has taken the ongoing Big Bash League BBL by storm, isnt thinking about a possible England recall and is instead engrossed in his game which may help him in lifting the trophy for Sydney Thunder. Hales was axed from Englands...

Saudi-led forces thwart attack by Yemen's Houthis - Al-Hadath TV

The Saudi-led coalition fighting against Yemens Houthi movement said it had thwarted an attack by the Houthis on Saturday towards the Saudi capital Riyadh, the kingdoms state-owned broadcaster Al-Hadath TV reported on its Twitter page.Since...

Give Feedback